59F-19668-47640
4 vaccinations
6 coded responses
30 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 335 / FL
- Registered
- 2021-04-21
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3X8-43730-23761
Child or adolescent in my care · Female · 2022-10-16
Timeline
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-04-21
Registered in v-safe
-
2021-04-21
Dose 2 — Pfizer-BioNTech
-
2021-04-21
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Chills, Joint pains, Muscle or body achesAdult check-in
-
2021-04-22
Survey response — days 1–6 daily, dose 2MedDRA: Pain in extremity — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painFree text: When arm starts to hurt all symptoms start comingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-04-24
- 2021-04-25
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-04-27
- 2021-04-28
- 2021-05-05
- 2021-05-12
-
2021-05-19
Survey response — day 28, dose 2MedDRA: Condition aggravated, Erythema multiforme, Pre-existing disease — Feeling: GoodFree text: I get (b)(6) on legs from pressure/unknown reasons. (B)(6) has been more intense with most recent outbreak. Possibly a shot symptomMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-26
- 2021-06-02
- 2021-07-21
- 2021-10-20
-
2021-11-26
Dose 3 — Pfizer-BioNTech
- 2021-12-29
- 2021-12-31
- 2022-01-07
-
2022-02-25
Survey response — 3 months, dose 3MedDRA: COVID-19, Medical counselling — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Had COVID · Healthcare visit (other): Spoke to primary Dr office staffMedDRA releases: 2024-11 · check-in free text available
-
2022-02-25
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-03-05
-
2022-03-10
Call successfulDoes not wish to fill out VAERS report
-
2022-05-27
Survey response — 6 months, dose 3MedDRA: Respiratory tract congestion — Feeling: GoodFree text: Congestion dailyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-11
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-16
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2022-10-17
Health check-in — days 1–6 daily, dose 4Feeling: Good · Chills, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2022-10-18
-
2022-10-25
Survey response — day 14, dose 4MedDRA: Headache — Feeling: GoodFree text: HeadachesMedDRA releases: 2024-11 · check-in free text available
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-22
- 2023-01-10
-
2023-04-11
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-21 | Pfizer-BioNTech | |
| 3 | 2021-11-26 | Pfizer-BioNTech | No |
| 4 | 2022-10-11 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-25 | Successful 2022-03-10 |
Does not wish to fill out VAERS report |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): When arm starts to hurt all symptoms start coming
Release 8 — day 28, dose 2
Symptoms: I get (b)(6) on legs from pressure/unknown reasons. (B)(6) has been more intense with most recent outbreak. Possibly a shot symptom
redacted (b)(6)
Release 11 — 3 months, dose 3
Release 11 — 6 months, dose 3
Symptoms: Congestion daily
Release 12 — day 14, dose 4
Symptoms: Headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Erythema multiforme | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release